Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ADIR discloses cytotoxic anthracene derivatives for leukemia and solid tumors

July 16, 1998

Vical and NCI initiate melanoma DNA vaccine trial

July 16, 1998

Phase I trial reports efficacy of chimeric MAb CH-14.18 in neuroblastoma

July 16, 1998

Indolocarbazoles for prostate disorders jointly developed by Cephalon and Kyowa Hakko

July 15, 1998

Fast track designation granted for FGN-1 in APC

July 15, 1998

Potent, broad-spectrum antitumor arylsulfonylimidazolidinone selected by Dong Wha

July 14, 1998

Spotlight on estrone sulfatase inhibitors for treatment of breast cancer

July 14, 1998

Vitamin D analogue EB-1089 acts via effects on IGF-I

July 14, 1998

IL-15 potentiates antitumor activity of 5-FU/leucovorin in colorectal cancer

July 14, 1998

Subtype-selective MMP inhibitors patented by Agouron, Syntex

July 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...